Which company whose motto is "science for a better life" owns a brand of genes that provides an herbicide resistance system?
8bfb825d6903c08957f95882c4c6ac9c
LibertyLink (gene) LibertyLink is a Bayer owned brand of genes for use in agriculture providing tolerance to Liberty herbicide and glufosinate (a.k.a. Liberty or Basta). The genes were developed by Bayer CropScience. LibertyLink provides an herbicide resistance system that is still effective in the presence of glyphosate resistant weeds. The gene which gives resistance to glufosinate is a bar or pat gene which was first isolated from two species of "Streptomyces" bacteria.
da99a41e40b581b25ebf45b11ddada03
Bayer Bayer AG ( or ); ] ) is a German multinational chemical, pharmaceutical and life sciences company. It is headquartered in Leverkusen, where its illuminated sign is a landmark. Bayer's primary areas of business include human and veterinary pharmaceuticals; consumer healthcare products; agricultural chemicals and biotechnology products; and high value polymers. The company is a component of the Euro Stoxx 50 stock market index. The company's motto is "science for a better life."
f02b3f8bec2d123d75ac4366ab42a4ea
Vi-Jon Laboratories Vi-Jon Laboratories is a health and beauty care company that produces both Private Label and brand name products. Headquartered in St. Louis, they operate five manufacturing and distribution centers in Missouri and Tennessee. The company's products are supplied nationwide to retailers such as Kroger, Target, and Walgreens. Vi-Jon was founded as Peroxide Specialty Company in 1908 by John B. Brunner. Vi-Jon has been owned by investment firm Berkshire Partners since 2006. The company markets a line of hand sanitizers in the United States under the brand Germ-X.
c68e78ac0afd055b1e9ea2702c208c98
GlobalStem GlobalStem, Inc. is a biotechnology company based in Rockville, Maryland.
341bcec61e7a16614fb08984f9c0938a
Drug resistance Drug resistance is the reduction in effectiveness of a medication such as an antimicrobial or an antineoplastic in curing a disease or condition. The term is used in the context of resistance that pathogens or cancers have "acquired", that is, resistance has evolved. Antimicrobial resistance and antineoplastic resistance challenge clinical care and drive research. When an organism is resistant to more than one drug, it is said to be multidrug-resistant. Even the immune system of an organism is in essence a drug delivery system, albeit endogenous, and faces the same arms race problems as external drug delivery.
edb4f036ac4c9da3f6dab5a6238e95f0
Genzyme Sanofi Genzyme is an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme has been a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world’s third-largest biotechnology company which employed more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme has a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products are also sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenue with more than 25 products in the market. In 2006 and 2007, Genzyme was named one of Fortune Magazine’s “100 Best Companies to Work for”. The company donated $83 million worth of products worldwide; in 2006, it made $11 million in cash donations. In 2005, Genzyme was awarded the National Medal of Technology, the highest level of honor awarded by the president of the United States to America’s leading innovators.
a4e07a2e6eee1fa8b2f44cbd6472c56c
ImmunoGen ImmunoGen, Inc. (NASDAQ: IMGN ) is a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts.
3fba385ff92295ceafea4217b69e5d53
ChromaDex ChromaDex is a publicly traded natural products company based in Irvine, California. The company is most well known for its industry standard phytochemical testing laboratories and catalogue. In cooperation with the University of Mississippi, the company is currently exploring the effects of pterostiibene on humans.
e53661308fc3bdfec408edfd8942a76b
Jeffrey M. Smith Jeffrey M. Smith (born 1958) is an American consumer activist, self-published author, and former politician. He is the author of two books on genetically engineered foods, "Seeds of Deception: Exposing Industry and Government Lies about the Safety of the Genetically Engineered Foods You’re Eating", and "Genetic Roulette: The Gamble of Our Lives", which he made into a film in 2012. He has appeared twice on "The Dr. Oz Show". Smith has worked with organic food marketers and alternative health product promoters to advocate against genetically modified food. Supporters identify Smith as an influential educator on the alleged risks associated with genetically modified foods, while others point out Smith's lack of scientific background or expertise in the field. In 1998, Smith ran unsuccessfully for Congress as a candidate for the Natural Law Party. As of 2010, Smith was the executive director and sole employee of the Institute for Responsible Technology; in 2012 paperwork to become a 501(c)3 was filed.
4e4cbf57b55781307de01cc524973c10
Prosol Prosol S.p.A. is an Italian biotechnology company headquartered in Madone, Lombardy region, Italy. Founded in 1974, it primarily develops and markets nutritional ingredients for the food industry and livestock area, especially yeast and yeast extracts, nucleotides, ribonucleic acid, probiotics and natural enhancers. Prosol has an in-house developed technology and its plants cover an area of 28000 sq. m, employing about 38 people and working both in domestic and international markets. The company is the original developer and distributor of Biosprint, an active dry yeast used for animal nutrition, and Ribomix, Ribocare, Levimaxi, Brist, Ribonucleic acid trademarks for human nutrition. The company has received the ISO, GMP+, IFS and OHSAS 18001 certifications.
1268897909ef17a8ff5f9f6ad1f8ff5f
Alnylam Pharmaceuticals Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, "Forbes" included the company on its "100 Most Innovative Growth Companies" list.
0448e682cf19aa3cb2744752d8c3769c
Illumina (company) Illumina, Inc. is an American company incorporated in April 1998 that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serve the sequencing, genotyping and gene expression and proteomics markets. Its headquarters are located in San Diego, California.
3951983713282a70320aa3744d3dbe14
Genset Corporation Genset, a biotechnology company, was established in 1989 in Paris, France with Pascal Brandys as its first president.
382f4dd02f845afed47d052466c366bf
Aminopyralid Aminopyralid is a selective herbicide used for control of broadleaf weeds, especially thistles and clovers. It is in the picolinic acid family of herbicides, which also includes clopyralid, picloram, triclopyr, and several less common herbicides. It was first registered for use in 2005, in the USA under the brand name "Milestone". and in the UK under the brand names Banish, Forefront, Halcyon, Pharaoh, Pro-Banish, Runway, Synero, and Upfront.
171c52e54eacd9b1b104442deb576bcb
Regeneron Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities (thus the name), it branched out into the study of both cytokine and tyrosine kinase receptors.
50c4053eec720bdb181091a7e4439ca1
Climate Counts Climate Counts, spearheaded by Stonyfield Farm CEO Gary Hirshberg, is a non-profit campaign that scores companies annually on the basis of their voluntary action to reverse climate change. The Climate Counts Company Scorecard—launched in June 2007—helps people vote with their dollars by making climate-conscious purchasing and investing choices that put pressure on the world's most well-known companies to take the issue of climate change seriously. Climate Counts aims to mobilize everyday consumers—not just the traditional environmental community—as the most important activists in the fight against global warming.
e1947cd620e1c0f2a1d13b1f55d0d1c0
Herbert Boyer Herbert Wayne "Herb" Boyer (born July 10, 1936) is a researcher and entrepreneur in biotechnology. Along with Stanley N. Cohen and Paul Berg he discovered a method to coax bacteria into producing foreign proteins, thereby jump starting the field of genetic engineering. He is recipient of the 1990 National Medal of Science, co-recipient of the 1996 Lemelson–MIT Prize, and a co-founder of Genentech. He was professor at the University of California, San Francisco (UCSF) and later served as Vice President of Genentech from 1976 until his retirement in 1991.
fb534540865ec8e244c3ecd3c4622dfb
Knome Knome, Inc. was a human genome interpretation company based in Cambridge, Massachusetts, USA. Since their 2007 launch, Knome’s sole focus has been on improving lives by applying scientific insights gained from the interpretation of human genomes. Their products and services help their clients identify and classify the variants, genes, and gene sets that are likely to govern or underlie a specific disease, tumor, or drug response. Clients include academic, pharmaceutical, and medical researchers. In 2015 it was taken over by Tute Genomics.
f7e6e7f2411e382ef5073b385d096ab3
MON 810 The MON 810 corn is a genetically modified maize used around the world. It is a "Zea mays" line known as YieldGard from the company Monsanto. This plant is a genetically modified organism (GMO) designed to combat crop loss due to insects. There is an inserted gene in the DNA of MON810 which allows the plant to make a protein that harms insects that try to eat it. The inserted gene is from the "Bacillus thuringiensis" which produces the Bt toxin that is poisonous to insects in the Lepidoptera order (butterflies and moths), including the European Corn Borer.
1e5e755135b638134dccbba2b1590dd9
Henri Termeer Henri A. Termeer (28 February 1946 – 12 May 2017) was a Dutch biotechnology executive and entrepreneur who is considered a pioneer in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme. Termeer created a business model adopted by many others in the biotech industry by garnering steep prices— mainly from insurers and government payers— for therapies for rare genetic disorders known as orphan diseases that mainly affect children. Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. The drugs are also protected by orphan drug acts in various countries which provides extensive protection from competition and ensures coverage by publicly funded insurers. As CEO of Genzyme from 1981 to 2011, he developed corporate strategies for growth including optimizing institutional embeddedness nurturing vast networks of influential groups and clusters: doctors, private equity, patient-groups, insurance, healthcare umbrella organizations, state and local government, alumni. Termeer is "connected to 311 board members in 17 different organizations across 20 different industries" including Verastem, Inc. He has the legacy of being the "longest-serving CEO in the biotechnology industry.
b04c0d9d5874dc9a6c761ff1850d6561
Sarepta Therapeutics Sarepta Therapeutics Inc. (NASDAQ: SRPT ) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980, the company maintains some laboratory capability in Corvallis, Oregon. s of 2014 , the company does not commercialize any approved drug. As of 2008, Sarepta has 170 issued medical patents, and over 150 patents pending. The company changed its name from AVI BioPharma and stock symbol from AVII in July 2012 to Sarepta Therapeutics and SRPT respectively.
8200201befde16df9cdf378c1d6ecdf8
Probiotic Probiotics are defined as live microorganisms that are believed to provide health benefits when consumed. The term probiotic is currently used to name ingested microorganisms associated with benefits for humans and animals. The term came into more common use after 1980. The introduction of the concept (but not the term) is generally attributed to Nobel laureate Élie Metchnikoff, who postulated that yogurt-consuming Bulgarian peasants lived longer lives because of this custom. He suggested in 1907 that "the dependence of the intestinal microbes on the food makes it possible to adopt measures to modify the flora in our bodies and to replace the harmful microbes by useful microbes". A significant expansion of the potential market for probiotics has led to higher requirements for scientific substantiation of putative benefits conferred by the microorganisms.